Anti‐cyclic citrullinated peptide: diagnostic and prognostic values in juvenile idiopathic arthritis and rheumatoid arthritis in a Chinese population

References

• Morrow J., Nelson L., Watts R., Isenberg D. Autoimmune rheumatic disease, 2nd ed. Oxford University Press, Oxford, New York 1999; 104–46
   Google Scholar
• Lau E., Symmons D., Bankhead C., MacGregor A., Donnan S., Silman A. Low prevalence of rheumatoid arthritis in the urbanized Chinese of Hong Kong. J Rheumatol 1993; 20: 1133–7
   PubMed Web of Science ®Google Scholar
• Arnett F. C., Edworthy S. M., Bloch D. A., McShane D. J., Fries J. F., Cooper N. S., et al. The American Rheumatism Association 1987 revised criteria for the classification of rheumatoid arthritis. Arthritis Rheum 1988; 31: 315–24
   PubMed Web of Science ®Google Scholar
• Mottonen T., Hannonen P., Korpela M., Nissila M., Kautiainen H., Ilonen J., et al. Delay to institution of therapy and induction of remission using single‐drug or combination‐disease‐modifying antirheumatic drug therapy in early rheumatoid arthritis. Arthritis Rheum 2002; 46: 894–8
   PubMed Web of Science ®Google Scholar
• O'Dell J. R. Treating rheumatoid arthritis early: a window of opportunity?. Arthritis Rheum 2002; 46: 283–5
   PubMed Web of Science ®Google Scholar
• Brennan P., Harrison B., Barrett E., Chakravarty K., Scott D., Silman A., et al. A simple algorithm to predict the development of radiological erosions in patients with early rheumatoid arthritis: prospective cohort study. Br Med J 1996; 313: 471–6
   PubMed Web of Science ®Google Scholar
• Kroot E. J., de Jong B. A., van Leeuwen M. A., Swinkels H., van den Hoogen F. H., van't Hof M., et al. The prognostic value of anti‐cyclic citrullinated peptide antibody in patients with recent‐onset rheumatoid arthritis. Arthritis Rheum 2000; 43: 1831–5
   PubMed Web of Science ®Google Scholar
• Rose H. M., Ragan C., Pearce E., Lipman M. O. Differential agglutination of normal and sensitized sheep erythrocytes by sera of patients with rheumatoid arthritis. Proc Soc Exp Biol Med 1949; 68: 1–6
   Web of Science ®Google Scholar
• Bas S., Perneger T. V., Kunzle E., Vischer T. L. Comparative study of different enzyme immunoassays for measurement of IgM and IgA rheumatoid factors. Ann Rheum Dis 2002; 61: 505–10
   PubMed Web of Science ®Google Scholar
• Saraux A., Berthelot J. M., Devauchelle V., Bendaoud B., Chales G., Le Henaff C., et al. Value of antibodies to citrulline‐containing peptides for diagnosing early rheumatoid arthritis. J Rheumatol 2003; 30: 2535–9
   PubMed Web of Science ®Google Scholar
• Bartfeld H. Incidence and significance of seropositive tests for rheumatoid factor in non‐rheumatoid disease. Ann Intern Med 1960; 52: 1059–66
   Web of Science ®Google Scholar
• Carson D. A. Rheumatoid factor. Textbook of rheumatology, W. N Kelly, S Ruddy, E. D Harris, C. B Sledge. Saunders, Philadelphia 1997; 155–63
   Google Scholar
• Shmerling R. H., Delbanco T. L. The rheumatoid factor: an analysis of clinical utility. Am J Med 1991; 91: 528–34
   PubMed Web of Science ®Google Scholar
• Bas S., Genevay S., Meyer O., Gabay C. Anti‐cyclic citrullinated peptide antibodies, IgM and IgA rheumatoid factors in the diagnosis and prognosis of rheumatoid arthritis. Rheumatology (Oxford) 2003; 42: 677–80
   PubMed Web of Science ®Google Scholar
• Visser H., le Cessie S., Vos K., Breedveld F. C., Hazes J. M. How to diagnose rheumatoid arthritis early: a prediction model for persistent (erosive) arthritis. Arthritis Rheum 2002; 46: 357–65
   PubMed Web of Science ®Google Scholar
• Schellekens G. A., de Jong B. A., van den Hoogen F. H., van de Putte L. B., van Venrooij W. J. Citrulline is an essential constituent of antigenic determinants recognized by rheumatoid arthritis‐specific autoantibodies. J Clin Invest 1998; 101: 273–81
   PubMed Web of Science ®Google Scholar
• Schaller J. G. Rheumatic diseases of children. Nelson textbook of pediatrics, 15th edn, W. E Nelson, R. E Behrman, R. M Kliegman, A. M Arvin. WB Saunders, Philadelphia 1996; 657–91
   Google Scholar
• Petty R. E., Southwood T. R., Manners P., Baum J., Glass D. N., Goldenberg J., et al. International League of Associations for Rheumatology classification of juvenile idiopathic arthritis: second revision, Edmonton, 2001. J Rheumatol 2004; 31: 390–2
   PubMed Web of Science ®Google Scholar
• Woo P., Wedderburn L. R. Juvenile chronic arthritis. Lancet 1998; 351: 969–73
   PubMed Web of Science ®Google Scholar
• Saraux A., Berthelot J. M., Chales G., Le Henaff C., Thorel J. B., Hoang S., et al. Ability of the American College of Rheumatology 1987 criteria to predict rheumatoid arthritis in patients with early arthritis and classification of these patients two years later. Arthritis Rheum 2001; 44: 2485–91
   PubMed Web of Science ®Google Scholar
• Leigh J. P., Fries J. F. Predictors of disability in a longitudinal sample of patients with rheumatoid arthritis. Ann Rheum Dis 1992; 51: 581–7
   PubMed Web of Science ®Google Scholar
• van Zeben D., Hazes J. M., Zwinderman A. H., Vandenbroucke J. P., Breedveld F. C. Factors predicting outcome of rheumatoid arthritis: results of a followup study. J Rheumatol 1993; 20: 1288–96
   PubMed Web of Science ®Google Scholar
• Welsing P. M., Landewe R. B., van Riel P. L., Boers M., van Gestel A. M., van der L. S., et al. The relationship between disease activity and radiologic progression in patients with rheumatoid arthritis: a longitudinal analysis. Arthritis Rheum 2004; 50: 2082–93
   PubMed Web of Science ®Google Scholar
• Matsuda Y., Yamanaka H., Higami K., Kashiwazaki S. Time lag between active joint inflammation and radiological progression in patients with early rheumatoid arthritis. J Rheumatol 1998; 25: 427–32
   PubMed Web of Science ®Google Scholar
• Jansen L. M., van Schaardenburg D., van der Horst‐Bruinsma I., van der Stadt R. J., de Koning M. H., Dijkmans B. A. The predictive value of anti‐cyclic citrullinated peptide antibodies in early arthritis. J Rheumatol 2003; 30: 1691–1695
   PubMed Web of Science ®Google Scholar
• Gottenberg J. E., Mignot S., Nicaise‐Rolland P., Cohen‐Solal J., Aucouturier F., Goetz J., et al. Prevalence of anti‐cyclic citrullinated peptide and anti‐keratin antibodies in patients with Sjögren's syndrome. Ann Rheum Dis 2005; 64: 114–17
   PubMed Web of Science ®Google Scholar
• Avcin T., Cimaz R., Falcini F., Zulian F., Martini G., Simonini G., et al. Prevalence and clinical significance of anti‐cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. Ann Rheum Dis 2002; 61: 608–11
   PubMed Web of Science ®Google Scholar
• Lee D. M., Schur P. H. Clinical utility of the anti‐CCP assay in patients with rheumatic diseases. Ann Rheum Dis 2003; 62: 870–4
   PubMed Web of Science ®Google Scholar
• van Boekel M. A., Vossenaar E. R., van den Hoogen F. H., van Venrooij W. J. Autoantibody systems in rheumatoid arthritis: specificity, sensitivity and diagnostic value. Arthritis Res 2002; 4: 87–93
   PubMedGoogle Scholar
• Palosuo T., Tilvis R., Strandberg T., Aho K. Filaggrin related antibodies among the aged. Ann Rheum Dis 2003; 62: 261–3
   PubMed Web of Science ®Google Scholar
• Mediwake R., Isenberg D. A., Schellekens G. A., van Venrooij W. J. Use of anti‐citrullinated peptide and anti‐RA33 antibodies in distinguishing erosive arthritis in patients with systemic lupus erythematosus and rheumatoid arthritis. Ann Rheum Dis 2001; 60: 67–8
   PubMed Web of Science ®Google Scholar
• van Noord C., Hooijkaas H., Dufour‐van den Goorbergh B. C., van Hagen P. M., van Daele P. L., van de Merwe J. P. Diagnostic value of anti‐cyclic citrullinated peptide antibodies to detect rheumatoid arthritis in patients with Sjögren's syndrome. Ann Rheum Dis 2005; 64: 160–2
   PubMed Web of Science ®Google Scholar
• van Paassen P., Damoiseaux J., Tervaert J. W. Laboratory assessment in musculoskeletal disorders. Best Pract Res Clin Rheumatol 2003; 17: 475–94
   PubMed Web of Science ®Google Scholar
• Bombardieri M., Alessandri C., Labbadia G., Iannuccelli C., Carlucci F., Riccieri V., et al. Role of anti‐cyclic citrullinated peptide antibodies in discriminating patients with rheumatoid arthritis from patients with chronic hepatitis C infection‐associated polyarticular involvement. Arthritis Res Ther 2004; 6: R137–41
   PubMed Web of Science ®Google Scholar
• Meyer O., Labarre C., Dougados M., Goupille P., Cantagrel A., Dubois A., et al. Anticitrullinated protein/peptide antibody assays in early rheumatoid arthritis for predicting five year radiographic damage. Ann Rheum Dis 2003; 62: 120–6
   PubMed Web of Science ®Google Scholar
• Nielen M. M., van Schaardenburg D., Reesink H. W., van de Stadt R. J., van der Horst‐Bruinsma I. E., de Koning M. H., et al. Specific autoantibodies precede the symptoms of rheumatoid arthritis: a study of serial measurements in blood donors. Arthritis Rheum 2004; 50: 380–6
   PubMed Web of Science ®Google Scholar
• van Gaalen F. A., Linn‐Rasker S. P., van Venrooij W. J., de Jong B. A., Breedveld F. C., Verweij C. L., et al. Autoantibodies to cyclic citrullinated peptides predict progression to rheumatoid arthritis in patients with undifferentiated arthritis: a prospective cohort study. Arthritis Rheum 2004; 50: 709–15
   PubMed Web of Science ®Google Scholar
• van Rossum M., van Soesbergen R., de Kort S., ten Cate R., Zwinderman A. H., de Jong B., et al. Anti‐cyclic citrullinated peptide (anti‐CCP) antibodies in children with juvenile idiopathic arthritis. J Rheumatol 2003; 30: 825–8
   PubMed Web of Science ®Google Scholar
• Low J. M., Chauhan A. K., Kietz D. A., Daud U., Pepmueller P. H., Moore T. L. Determination of anti‐cyclic citrullinated peptide antibodies in the sera of patients with juvenile idiopathic arthritis. J Rheumatol 2004; 31: 1829–33
   PubMed Web of Science ®Google Scholar
• Kasapcopur O., Altun S., Aslan M., Karaarslan S., Kamburoglu‐Goksel A., Saribas S., et al. Diagnostic accuracy of anti‐cyclic citrullinated peptide antibodies in juvenile idiopathic arthritis. Ann Rheum Dis 2004; 63: 1687–9
   PubMed Web of Science ®Google Scholar
• Cassidy J. T., Petty R. E. Textbook of pediatric rheumatology. W.B. Saunders, Philadelphia 2001; 233–5
   Google Scholar
• van Jaarsveld C. H., ter Borg E. J., Jacobs J. W., Schellekens G. A., Gmelig‐Meyling F. H., Booma‐Frankfort C., et al. The prognostic value of the antiperinuclear factor, anti‐citrullinated peptide antibodies and rheumatoid factor in early rheumatoid arthritis. Clin Exp Rheumatol 1999; 17: 689–97
   PubMed Web of Science ®Google Scholar
• Kastbom A., Strandberg G., Lindroos A., Skogh T. Anti‐CCP antibody test predicts the disease course during 3 years in early rheumatoid arthritis (the Swedish TIRA project). Ann Rheum Dis 2004; 63: 1085–9
   PubMed Web of Science ®Google Scholar